Search filters

List of works by Claudia Sandomenico

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

scientific article published on 27 February 2017

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

scientific article published in July 2013

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

scientific article published on October 2013

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

scientific article published on 12 August 2015

Angiogenesis Inhibitors in NSCLC.

scientific article published on 21 September 2017

Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells

scientific article published on 01 October 1997

Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet

scientific article published in January 2010

Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer

scientific article

Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence

scientific article published on January 2008

Central venous device-related thrombosis as imaged with MDCT in oncologic patients: prevalence and findings

scientific article published in March 2011

Cetuximab in non-small-cell lung cancer

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

scientific article published on January 2014

Focus on Nintedanib in NSCLC and Other Tumors

scientific article published on 19 December 2016

Gefitinib in non small cell lung cancer

scientific article

Immunotherapy in Small Cell Lung Cancer

scientific article published on 04 September 2020

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

scientific article published on July 2013

Is preoperative endoscopic biliary drainage indicated for jaundiced patients with resectable pancreatic cancer?

scientific article published on June 2012

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

scientific article published on 3 February 2009

Pembrolizumab in lung cancer: current evidence and future perspectives

scientific article published on 21 August 2019

Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.

scientific article

Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy

scientific article published on July 2008

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

scientific article published on 31 January 2012

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

scientific article published in May 2013

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

scientific article

Role of oxaliplatin in the treatment of colorectal cancer

scientific article published on February 2009

The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer

scientific article published on 13 May 2020

Treatment of small cell lung cancer

scholarly article by Alessandro Morabito et al published September 2014 in Critical Reviews in Oncology Hematology

de Gramont schedule is a very low toxic and effective regimen in low performance status patients affected by metastatic gastric cancer: preliminary report

scientific article published in July 2002

Paulina is supported by:

About Paulina

Help